Takeda Pharmaceutical Co Ltd (TAK)
13.28
+0.08
(+0.64%)
USD |
NYSE |
May 02, 12:03
Takeda Pharmaceutical Accounts Payable (Quarterly): 3.430B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.430B |
September 30, 2023 | 2.819B |
June 30, 2023 | 3.045B |
March 31, 2023 | 2.307B |
December 31, 2022 | 2.907B |
September 30, 2022 | 2.69B |
June 30, 2022 | 3.107B |
March 31, 2022 | 2.425B |
December 31, 2021 | 3.052B |
September 30, 2021 | 3.007B |
June 30, 2021 | 2.901B |
March 31, 2021 | 2.104B |
December 31, 2020 | 3.170B |
September 30, 2020 | 2.581B |
June 30, 2020 | 2.693B |
March 31, 2020 | 1.958B |
December 31, 2019 | 2.754B |
September 30, 2019 | 2.597B |
June 30, 2019 | 2.585B |
March 31, 2019 | 1.915B |
December 31, 2018 | 2.253B |
September 30, 2018 | 1.986B |
June 30, 2018 | 2.040B |
March 31, 2018 | 1.258B |
December 31, 2017 | 1.982B |
Date | Value |
---|---|
September 30, 2017 | 1.864B |
June 30, 2017 | 1.960B |
March 31, 2017 | 2.152B |
December 31, 2016 | 1.993B |
September 30, 2016 | 1.945B |
June 30, 2016 | 1.851B |
March 31, 2016 | 1.700B |
December 31, 2015 | 1.414B |
September 30, 2015 | 1.315B |
June 30, 2015 | 1.409B |
March 31, 2015 | 1.423B |
December 31, 2014 | 1.410B |
September 30, 2014 | 1.419B |
June 30, 2014 | 1.526B |
March 31, 2014 | 1.797B |
December 31, 2013 | 1.171B |
September 30, 2013 | 1.103B |
June 30, 2013 | 1.080B |
March 31, 2013 | 1.804B |
December 31, 2012 | 1.264B |
September 30, 2012 | 1.262B |
June 30, 2012 | 1.253B |
March 31, 2012 | 2.140B |
December 31, 2011 | 1.261B |
September 30, 2011 | 1.171B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.958B
Minimum
Mar 2020
3.430B
Maximum
Dec 2023
2.744B
Average
2.754B
Median
Dec 2019
Accounts Payable (Quarterly) Benchmarks
Hoya Corp | 474.49M |
Astellas Pharma Inc | 1.067B |
Nxera Pharma Co Ltd | 30.09M |
PeptiDream Inc | 22.72M |
Stemcell Holdings Inc | 0.4007M |